Qinlock 50 mg Tablet – Uses, Dosage, Side Effects & Safety

BANGALORE, India - Sept. 3, 2025 - PRLog -- Qinlock 50 mg Tablet contains Ripretinib, a targeted cancer medicine belonging to the class of tyrosine kinase inhibitors (TKIs). It is specifically designed for the treatment of advanced gastrointestinal stromal tumors (GIST) in adult patients who have already been treated with at least three or more kinase inhibitors, including imatinib.

Qinlock works by blocking multiple mutant forms of KIT and PDGFRA kinases, which are responsible for driving tumor growth in GIST. By targeting these pathways, it helps slow down or stop the progression of the disease.

Key Benefits of Qinlock 50 mg Tablet:

• Effective treatment for advanced or drug-resistant GIST
• Targets multiple mutations in KIT and PDGFRA
• Improves survival rates in late-stage GIST patients
• Oral tablet formulation for convenient use

How to Use:
Qinlock should be taken once daily with food, exactly as prescribed by your oncologist. The dose should not be changed or stopped without medical advice.

Possible Side Effects:
Hair thinning, fatigue, nausea, diarrhea, muscle pain, and decreased appetite. Some patients may experience more serious side effects such as skin reactions, high blood pressure, or heart-related issues, requiring medical monitoring.

It is not a first-line treatment and is usually considered when other therapies are no longer effective.

Buy >  QINLOCK 50 ONLINE
https://www.drugsgeneral.com/qinlock-50-mg-tablet/ (https://www.drugsgeneral.com/qinlock-50-mg-tablet/)